Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Strength training is crucial after menopause. How to make the most of your workouts - 2RSF attack on Sudan’s South Kordofan kills at least 14, including children
- 3Damaged Shenzhou-20 spacecraft to return to Earth uncrewed for inspection
- 4Ringleader of suspected human trafficking network arrested in Ethiopia
- 5Remains of banker missing since 1999 found on California beach by family looking for seashells
- Make your choice for the music application with the most amicable connection point!
- South America's Memorable Destinations: A Movement Guide
- Indonesian Mega-Farm Drives Surge in Deforestation
- She was moments away from giving birth. The hospital discharged her
- Top 10 Smash hit Computer games of the Year
- Science is best communicated through identity and culture – how researchers are ensuring STEM serves their communities
- Reclassifying Achievement: Individual Accounts of Seeking after Interests
- Enormous Credit And All that You Really want To Be aware
- ‘The White Lotus’ sparked online interest in risky anxiety pills, study says
